Prediction of soft tissue sarcoma response to radiotherapy using longitudinal diffusion MRI and a deep neural network with generative adversarial network-based data augmentation.


Journal

Medical physics
ISSN: 2473-4209
Titre abrégé: Med Phys
Pays: United States
ID NLM: 0425746

Informations de publication

Date de publication:
Jun 2021
Historique:
revised: 18 02 2021
received: 19 05 2020
accepted: 12 04 2021
pubmed: 29 4 2021
medline: 10 7 2021
entrez: 28 4 2021
Statut: ppublish

Résumé

The goal of this study was to predict soft tissue sarcoma response to radiotherapy (RT) using longitudinal diffusion-weighted MRI (DWI). A novel deep-learning prediction framework along with generative adversarial network (GAN)-based data augmentation was investigated for the response prediction. Thirty soft tissue sarcoma patients who were treated with five-fraction hypofractionated radiation therapy (RT, 6Gy×5) underwent diffusion-weighted MRI three times throughout the RT course using an MR-guided radiotherapy system. Pathologic treatment effect (TE) scores, ranging from 0-100%, were obtained from the post-RT surgical specimen as a surrogate of patient treatment response. Patients were divided into three classes based on the TE score (TE ≤ 20%, 20% < TE < 90%, TE ≥ 90%). Apparent diffusion coefficient (ADC) maps of the tumor from the three time points were combined as 3-channel images. An auxiliary classifier generative adversarial network (ACGAN) was trained on 20 patients to augment the data size. A total of 15,000 synthetic images were generated for each class. A prediction model based on a previously described VGG-19 network was trained using the synthesized data, validated on five unseen validation patients, and tested on the remaining five test patients. The entire process was repeated seven times, each time shuffling the training, validation, and testing datasets such that each patient was tested at least once during the independent test stage. Prediction performance for slice-based prediction and patient-based prediction was evaluated. The average training and validation accuracies were 86.5% ± 1.6% and 84.8% ± 1.8%, respectively, indicating that the generated samples were good representations of the original patient data. Among the seven rounds of testing, slice by slice prediction accuracy ranged from 81.6% to 86.8%. The overall accuracy of the independent test sets was 83.3%. For patient-based prediction, 80% was achieved in one round and 100% was achieved in the remaining six rounds. The mean accuracy was 97.1%. This study demonstrated the potential to use deep learning to predict the pathologic treatment effect from longitudinal DWI. Accuracies of 83.3% and 97.1% were achieved on independent test sets for slice-based and patient-based prediction respectively.

Identifiants

pubmed: 33908045
doi: 10.1002/mp.14897
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3262-3372

Informations de copyright

© 2021 American Association of Physicists in Medicine.

Références

Coindre JM, Terrier P, Guillou L, et al. Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: A study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer. 2001;91:1914-1926.
Wang X, Jacobs M, Fayad L. Therapeutic response in musculoskeletal soft tissue sarcomas: Evaluation by magnetic resonance imaging. NMR Biomed. 2011;24:750-763.
Soldatos T, Ahlawat S, Montgomery E, Chalian M, Jacobs MA, Fayad LM. Multiparametric assessment of treatment response in high-grade soft-tissue sarcomas with anatomic and functional MR imaging sequences. Radiology. 2016;278:831-840.
Yoshida S, Koga F, Kawakami S, et al. Initial experience of diffusion-weighted magnetic resonance imaging to assess therapeutic response to induction chemoradiotherapy against muscle-invasive bladder cancer. Urology. 2010;75:387-391.
Dudeck O, Zeile M, Pink D, et al. Diffusion-weighted magnetic resonance imaging allows monitoring of anticancer treatment effects in patients with soft-tissue sarcomas. J Magn Reson Imaging JMRI. 2008;27:1109-1113.
Schnapauff D, Zeile M, Niederhagen MB, et al. Diffusion-weighted echo-planar magnetic resonance imaging for the assessment of tumor cellularity in patients with soft-tissue sarcomas. J Magn Reson Imaging. 2009;29:1355-1359.
Uhl M, Saueressig U, van Buiren M, et al. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging. Invest Radiol. 2006;41:618-623.
Oka K, Yakushiji T, Sato H, Hirai T, Yamashita Y, Mizuta H. The value of diffusion-weighted imaging for monitoring the chemotherapeutic response of osteosarcoma: A comparison between average apparent diffusion coefficient and minimum apparent diffusion coefficient. Skeletal Radiol. 2010;39:141-146.
Tanner MA, Wong WH. The calculation of posterior distributions by data augmentation. J Am Stat Assoc. 1987;82:528-540.
Krizhevsky A, Sutskever I, Hinton GE. ImageNet classification with deep convolutional neural networks. Commun ACM. 2017;60:84-90.
Goodfellow I, Pouget-Abadie J, Mirza M, et al. Generative Adversarial Nets. In: Ghahramani Z, Welling M, Cortes C, Lawrence ND, Weinberger KQ, eds. Advances in Neural Information Processing Systems 27. Curran Associates, Inc.; 2014:2672-2680.Accessed May 6, 2019. http://papers.nips.cc/paper/5423-generative-adversarial-nets.pdf
Xue Y, Xu T, Zhang H, Long R, Huang X. SegAN: Adversarial network with multi-scale $L_1$ loss for medical image segmentation. Neuroinformatics. 2018;16:383-392.
Nie D, Trullo R, Petitjean C, Ruan S, Shen D. Medical image synthesis with context-aware generative adversarial networks. ArXiv161205362 Cs. 2016. Accessed May 6, 2019. http://arxiv.org/abs/1612.05362
Frid-Adar M, Diamant I, Klang E, Amitai M, Goldberger J, Greenspan H. GAN-based synthetic medical image augmentation for increased CNN performance in liver lesion classification. Neurocomputing. 2018;321:321-331.
Kalbasi A, Kamrava M, Chu F-I, et al. A phase 2 trial of five-day neoadjuvant radiation therapy for patients with high-risk primary soft tissue sarcoma. Clin Cancer Res. 2020. https://doi.org/10.1158/1078-0432.CCR-19-3524
Roberge D, Skamene T, Nahal A, Turcotte RE, Powell T, Freeman C. Radiological and pathological response following pre-operative radiotherapy for soft-tissue sarcoma. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2010;97:404-407.
Schaefer I-M, Hornick JL, Barysauskas CM, et al. Histologic appearance after preoperative radiation therapy for soft tissue sarcoma: Assessment of the European Organization for Research and treatment of cancer-soft tissue and bone sarcoma group response score. Int J Radiat Oncol Biol Phys. 2017;98:375-383.
Wardelmann E, Haas RL, Bovée JVMG, et al. Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) recommendations for pathological examination and reporting. Eur J Cancer Oxf Engl. 1990;2016:84-95.
Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F. WHO Classification of Tumours of Soft Tissue and Bone. Accessed January 28, 2020. https://publications.iarc.fr/Book-And-Report-Series/Who-Iarc-Classification-Of-Tumours/WHO-Classification-Of-Tumours-Of-Soft-Tissue-And-Bone-2013
Odena A, Olah C, Shlens J. Conditional image synthesis with auxiliary classifier GANs. ArXiv161009585 Cs Stat. 2016. Accessed May 6, 2019. http://arxiv.org/abs/1610.09585
Simonyan K, Zisserman A. Very deep convolutional networks for large-scale image recognition. ArXiv14091556 Cs. 2014. Accessed May 6, 2019. http://arxiv.org/abs/1409.1556
Wang S, Liu W, Wu J, Cao L, Meng Q, Kennedy PJ. Training deep neural networks on imbalanced data sets. In: 2016 International Joint Conference on Neural Networks (IJCNN); 2016:4368-4374. https://doi.org/10.1109/IJCNN.2016.7727770.
Zhang C, Bengio S, Hardt M, Recht B, Vinyals O. Understanding deep learning requires rethinking generalization. ArXiv161103530 Cs. 2016. Accessed July 22, 2019. http://arxiv.org/abs/1611.03530
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7-30.
Salimans T, Goodfellow I, Zaremba W, et al. Improved Techniques for Training GANs. In: Lee DD, Sugiyama M, Luxburg UV, Guyon I, Garnett R, eds. Advances in Neural Information Processing Systems 29. Curran Associates, Inc.; 2016:2234-2242.Accessed May 6, 2019. http://papers.nips.cc/paper/6125-improved-techniques-for-training-gans.pdf
Heusel M, Ramsauer H, Unterthiner T, Nessler B, Hochreiter S. GANs trained by a two time-scale update rule converge to a local nash equilibrium. In: Guyon I, Luxburg UV, Bengio S, eds. Advances in Neural Information Processing Systems 30. Curran Associates, Inc.; 2017:6626-6637.Accessed May 6, 2019. http://papers.nips.cc/paper/7240-gans-trained-by-a-two-time-scale-update-rule-converge-to-a-local-nash-equilibrium.pdf
Borji A. Pros and cons of GAN evaluation measures. Comput Vis Image Underst. 2019;179:41-65.
Shmelkov K, Schmid C, Alahari K. How good is my GAN? ArXiv180709499 Cs. 2018. Accessed May 3, 2019. http://arxiv.org/abs/1807.09499
Selvaraju RR, Cogswell M, Das A, Vedantam R, Parikh D, Batra D. Grad-CAM: Visual explanations from deep networks via gradient-based localization. In: 2017 IEEE International Conference on Computer Vision (ICCV); 2017:618-626. https://doi.org/10.1109/ICCV.2017.74
Eilber FC, Rosen G, Eckardt J, et al. Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas. J Clin Oncol Off J Am Soc Clin Oncol. 2001;19:3203-3209.

Auteurs

Yu Gao (Y)

Department of Radiological Sciences, University of California, Los Angeles, CA, USA.
Physics and Biology in Medicine IDP, University of California, Los Angeles, CA, USA.

Vahid Ghodrati (V)

Department of Radiological Sciences, University of California, Los Angeles, CA, USA.
Physics and Biology in Medicine IDP, University of California, Los Angeles, CA, USA.

Anusha Kalbasi (A)

Department of Radiation Oncology, University of California, Los Angeles, CA, USA.

Jie Fu (J)

Physics and Biology in Medicine IDP, University of California, Los Angeles, CA, USA.
Department of Radiation Oncology, University of California, Los Angeles, CA, USA.

Dan Ruan (D)

Physics and Biology in Medicine IDP, University of California, Los Angeles, CA, USA.
Department of Radiation Oncology, University of California, Los Angeles, CA, USA.

Minsong Cao (M)

Physics and Biology in Medicine IDP, University of California, Los Angeles, CA, USA.
Department of Radiation Oncology, University of California, Los Angeles, CA, USA.

Chenyang Wang (C)

Department of Radiation Oncology, University of California, Los Angeles, CA, USA.

Fritz C Eilber (FC)

Division of Surgical Oncology, Department of Surgery, University of California, Los Angeles, CA, USA.

Nicholas Bernthal (N)

Department of Orthopaedic Surgery, University of California, Los Angeles, CA, USA.

Susan Bukata (S)

Department of Orthopaedic Surgery, University of California, Los Angeles, CA, USA.

Sarah M Dry (SM)

Department of Pathology, University of California, Los Angeles, CA, USA.

Scott D Nelson (SD)

Department of Pathology, University of California, Los Angeles, CA, USA.

Mitchell Kamrava (M)

Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

John Lewis (J)

Physics and Biology in Medicine IDP, University of California, Los Angeles, CA, USA.
Department of Radiation Oncology, University of California, Los Angeles, CA, USA.

Daniel A Low (DA)

Physics and Biology in Medicine IDP, University of California, Los Angeles, CA, USA.
Department of Radiation Oncology, University of California, Los Angeles, CA, USA.

Michael Steinberg (M)

Department of Radiation Oncology, University of California, Los Angeles, CA, USA.

Peng Hu (P)

Department of Radiological Sciences, University of California, Los Angeles, CA, USA.
Physics and Biology in Medicine IDP, University of California, Los Angeles, CA, USA.

Yingli Yang (Y)

Physics and Biology in Medicine IDP, University of California, Los Angeles, CA, USA.
Department of Radiation Oncology, University of California, Los Angeles, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH